The New York Times
When Juliet Jacobs found out she had lung , she was terrified, but realized that her hope lay in getting the best treatment medicine could offer. So she got a second opinion, then a third. In February of 2010, she ended up at , where she entered a research study whose promise seemed stunning.
Doctors would assess her cells, looking for gene patterns that would determine which drugs would best attack her particular cancer. She would not waste precious time with ineffective drugs or trial-and-error treatment... Read More